New approaches in cancer prevention, diagnosis and monitoring
What does this approach include?
Diagnosis at an early stage of nearly all cancer entities is critical for successful therapeutic intervention. The availability of novel molecular and imaging tools form the basis for the development of new markers and strategies not only for diagnosis but also for prevention and disease monitoring. This research is fostered by existing Core Units (e.g. Core Unit Chip Application), cooperation within networks of excellence, e. g. the European LeukemiaNet, and association to integrated research centers (e. g. IZKF, ZeMOP). The research activities in this field are highlighted by translational projects which deal with chip based diagnosis on gene, protein and epigenetic level as well as nanotechnology, antibody-based therapy and imaging techniques.
Here we present two interdisciplinary projects which focus on the early detection of cancer. One project deals with identification and validation of biomarkers for the detection of asymptomatic ovarian and renal cell carcinomas. The other project uses a multimodal imaging approach to detect early stages of cancers in the aero-digestive tract.
Coordinators
Participants
F. von Eggeling - Institute of Human Genetics
I. Hilgers - Institute of Radiology
M. Dürst - Clinic of Gynecology
K. Pachmann, J. Clement and A. Hochhaus, Department of Hematology and Oncology
A. Berndt - JUH Institute of Pathology
F. Böhmer - Center for Molecular Biomedicine
Faculty of Biology and Pharmacy (Friedrich Schiller Universität Jena)
the Leibnitz Institute of Age Research - Fritz-Lipmann Institute (M. Platzer)
Institute of Photonic Technologies Jena (IPHT, J. Popp and colleagues)
research cooperations outside of Jena
Core Units (Core Unit Chip Application) in association with European LeukemiaNet, IZKF
Publications
- Pachmann K, Camara O, Kavallaris A, Krauspe S, Malarski N, Gajda M, Kroll T, Jörke C, Hammer U, Altendorf-Hofmann A, Rabenstein C, Pachmann U, Runnebaum I, Höffken K. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol. 2008 Mar 10;26(8):1208-15.
- Lisy MR, Goermar A, Thomas C, Pauli J, Resch-Genger U, Kaiser WA, Hilger I. In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice. Radiology. 2008 Jun;247(3):779-87.
- Kraus I, Driesch C, Vinokurova S, Hovig E, Schneider A, von Knebel Doeberitz M, Dürst M. The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer Res. 2008 Apr 1;68(7):2514-22.
- Müller MC, Erben P, Saglio G, Gottardi E, Nyvold CG, Schenk T, Ernst T, Lauber S, Kruth J, Hehlmann R, Hochhaus A; European LeukemiaNet. Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories. Leukemia. 2008 Jan;22(1):96-102.
- Wehder L, Ernst G, Crecelius AC, Guntinas-Lichius O, Melle C, Schubert US, von Eggeling F. Depicting the spatial distribution of proteins in human tumor tissue combining SELDI and MALDI imaging and immunohistochemistry. J Histochem Cytochem. 2010;58(10):929-37. Epub 2010 Jul 19.